Mr George Irvin Paskewitz, MD | |
995 E Highway 33, Suite 1, Crete, NE 68333-2551 | |
(402) 826-5858 | |
(402) 826-5859 |
Full Name | Mr George Irvin Paskewitz |
---|---|
Gender | Male |
Speciality | Psychiatry & Neurology - Psychiatry |
Location | 995 E Highway 33, Crete, Nebraska |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134130347 | NPI | - | NPPES |
47077425426 | Medicaid | NE | |
47075636926 | Medicaid | NE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0800X | Psychiatry & Neurology - Psychiatry | 18851 (Nebraska) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr George Irvin Paskewitz, MD 995 E Highway 33, Suite 1, Crete, NE 68333-2551 Ph: (402) 826-5858 | Mr George Irvin Paskewitz, MD 995 E Highway 33, Suite 1, Crete, NE 68333-2551 Ph: (402) 826-5858 |
News Archive
Schizotypal traits and genetic liability for schizophrenia are associated with reduced cognitive functioning in patients with mood disorders, Japanese study results show.
The hypothesis that blood clotting disorders may explain some of the worst symptoms of COVID-19, including respiratory failure and pulmonary fibrosis, was suggested in mid-April by researchers in Brazil affiliated with the University of São Paulo's Medical School (FM-USP) via an article accepted for publication by the Journal of Thrombosis.
January is Glaucoma Awareness Month. The National Eye Institute, part of NIH, is highlighting key facts about this blinding disease, important tips for prevention and treatment, and research updates you may not know about.
"Healthcare is now shifting towards predictive and preventative care utilizing diagnostics that allow physicians to follow the course of a disease, evaluate which therapeutic regimes are most effective, and determine long-term susceptibility and recurrence," said G. Steven Burrill, CEO of Burrill & Company. "As diseases are better understood at a molecular level, the promise of personalized medicine is becoming a reality.
Although diffuse large B-cell lymphoma (DLBCL) is a curable disease in most patients aged 65 years or older, these patients are also at higher risk of chemotherapy-related death within the first 30 days of treatment.
› Verified 4 days ago